IMMUCELL CORP /DE/
10-Q, EX-27, 2000-08-10
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IMMUCELL CORP /DE/, 10-Q, EX-10.4, 2000-08-10
Next: SITI-SITES COM INC, SC 13D/A, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S
UNAUDITED FINANCIAL STATEMENTS FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000 AS
REPORTED ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                                              <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                                DEC-31-2000
<PERIOD-END>                                     JUN-30-2000
<CASH>                                             1,785,153
<SECURITIES>                                               0
<RECEIVABLES>                                        863,116
<ALLOWANCES>                                          39,360
<INVENTORY>                                          569,610
<CURRENT-ASSETS>                                   3,247,611
<PP&E>                                             1,714,493
<DEPRECIATION>                                       933,644
<TOTAL-ASSETS>                                     4,266,800
<CURRENT-LIABILITIES>                                416,996
<BONDS>                                              424,587
                                      0
                                                0
<COMMON>                                           3,425,217
<OTHER-SE>                                                 0
<TOTAL-LIABILITY-AND-EQUITY>                       4,266,800
<SALES>                                            1,427,952
<TOTAL-REVENUES>                                   1,458,885
<CGS>                                                726,559
<TOTAL-COSTS>                                      1,409,192
<OTHER-EXPENSES>                                     (24,317)
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                     9,577
<INCOME-PRETAX>                                       64,433
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                                   64,433
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                          64,433
<EPS-BASIC>                                             0.02
<EPS-DILUTED>                                           0.02


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission